Search - tctmd.com

Displaying 1 - 20 of 209

Sort: Relevancy | Date

News Daily News

Year in Review: Evidence Around AI in Cardiology Grows

Todd Neale

December 23, 2025

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

News Conference News AHA 2025

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Michael O'Riordan

November 11, 2025

News Daily News

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

L.A. McKeown

November 04, 2025

News Conference News TCT 2025

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Yael L. Maxwell

October 28, 2025

News Daily News

Biomarkers Added to a Polygenic Risk Score Equals Better CAD Prediction

Yael L. Maxwell

October 23, 2025

News Daily News

Type 2 MI Diagnoses on the Rise, but Best Course of Action Unknown

Caitlin E. Cox

October 08, 2025

News Daily News

Novel Biomarker GDF-15 Helps Risk-Stratify Patients With Suspected ACS

Todd Neale

October 03, 2025

News Daily News

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

Michael O'Riordan

September 23, 2025

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

News Daily News

Troponin Spikes After Exercise Not Linked to CAD in Middle-aged Athletes

Michael O'Riordan

June 20, 2025

News Conference News European Congress on Obesity 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

News Conference News ACC 2025

AI Shows Promise in Detecting Type 1 MI and Need for Revascularization

Yael L. Maxwell

April 07, 2025

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

News Daily News

High-Sensitivity Troponin Assays Not All the Same, APACE Data Confirm

Caitlin E. Cox

January 27, 2025

Presentation TCT 2024

TCT 719: Coronary Microvascular Resistance and High Sensitivity Troponin After Elective Percutaneous Coronary Intervention

Presenter: Danilo Maksud

October 30, 2024

News Conference News ESC 2024

AI Tool Fails to Boost Outcomes in ED Triage of Suspected CV Conditions

Caitlin E. Cox

September 12, 2024

News Daily News

Point-of-Care High-Sensitivity Assay for Troponin I Compares Well With Central Labs

L.A. McKeown

August 15, 2024

News Daily News

CMR Could Change Diagnosis, Management of Suspected NSTEMI: OxAMI

Yael L. Maxwell

July 18, 2024

News Daily News

ACC Chest Pain Pathway Performs Well Overall, Less So for Those With CAD

Yael L. Maxwell

March 28, 2024

Advertisement

Year in Review: Evidence Around AI in Cardiology Grows

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Biomarkers Added to a Polygenic Risk Score Equals Better CAD Prediction

Type 2 MI Diagnoses on the Rise, but Best Course of Action Unknown

Novel Biomarker GDF-15 Helps Risk-Stratify Patients With Suspected ACS

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Troponin Spikes After Exercise Not Linked to CAD in Middle-aged Athletes

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

AI Shows Promise in Detecting Type 1 MI and Need for Revascularization

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

High-Sensitivity Troponin Assays Not All the Same, APACE Data Confirm

TCT 719: Coronary Microvascular Resistance and High Sensitivity Troponin After Elective Percutaneous Coronary Intervention

AI Tool Fails to Boost Outcomes in ED Triage of Suspected CV Conditions

Point-of-Care High-Sensitivity Assay for Troponin I Compares Well With Central Labs

CMR Could Change Diagnosis, Management of Suspected NSTEMI: OxAMI

ACC Chest Pain Pathway Performs Well Overall, Less So for Those With CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content